header-langage
简体中文
繁體中文
English
Tiếng Việt
한국어
日本語
ภาษาไทย
Türkçe
Scan to Download the APP
Partnered With:

Sellas Life Sciences shares soar 300% premarket on cancer trial data

BlockBeats news, November 17, according to BIT stock platform data, Sellas Life Sciences pre-market shares soared 300% due to cancer trial data.

This news is presented with Gate Gate Money, one-stop Crypto, stocks, payments, and asset management
举报 Correction/Report
RelatedRecommended
Talk to someone with a historical perspective on the digital community
"Halo has not yet taken a snapshot, so do it now."
Correction/Report
Submit
Add Library
Visible to myself only
Public
Save
Choose Library
Add Library
Cancel
Finish